TABLE 5

Treatment-related adverse events

EventNo. of patients
Combination therapyMonotherapy
Treatment failure1a3b
Acute kidney injury01
Asymptomatic elevated CPKc01
Eosinophilic pneumonia1d0
  • a Occurred after de-escalation to ceftaroline monotherapy.

  • b Early failure prompting switch to combination therapy at day 5 of therapy.

  • c CPK, creatine phosphokinase.

  • d Occurred after de-escalation to daptomycin monotherapy.